About Shinpung Pharmaceutical
Shinpung Pharmaceutical is a company based in Seoul (South Korea) founded in 1962. The company has 832 employees. Shinpung Pharmaceutical offers products and services including Pyramax and Health Functional Foods.
- Headquarter Seoul, South Korea
- Employees 832
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website shinpoong.co.kr
- Social X
- Legal Name Shinpoong Pharmaceutical Co., Ltd.
- Annual Revenue$162.5 M (USD)6.15as on Dec 31, 2025
- Net Profit$6.11 M (USD)0as on Dec 31, 2025
- EBITDA$17.72 M (USD)0as on Dec 31, 2025
- Employee Count832
Products & Services of Shinpung Pharmaceutical
Shinpung Pharmaceutical offers a comprehensive portfolio of products and services, including Pyramax and Health Functional Foods.
An antimalarial drug that is manufactured and supplied for malaria treatment
Supplements such as Addmiles for cognitive health that are developed and marketed for everyday wellness
IPO & Listings of Shinpung Pharmaceutical
Shinpung Pharmaceutical is a publicly listed company on the KRX with ticker symbol 019170 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Jan 1990
- Listed onKRX: 19170
- Listed entityShinpoong Pharmaceutical Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7019170000
- Share price9,780.00 KRW (-11.17% on the day) · 2026-10-08
- Market capitalisation502,033,700,347.00 KRW
- EPS (diluted, trailing year)-9.13 KRW
- Volume (last session)835,856
Financials of Shinpung Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 234.68B KRW | 8.83B KRW | 25.59B KRW |
| 2024 | 221.09B KRW | -15.39B KRW | -7.28B KRW |
| 2023 | 200.23B KRW | -57.33B KRW | -37.07B KRW |
| 2022 | 209.29B KRW | -35.38B KRW | -21.22B KRW |
| 2021 | 189.24B KRW | -11.58B KRW | -1.63B KRW |
Detailed financial statements for Shinpung Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Shinpung Pharmaceutical
The website of Shinpung Pharmaceutical (shinpoong.co.kr) receives about 43.9K visits a month and ranks #583,901 among all websites worldwide, #609 in Biotechnology and Pharmaceuticals.
- Monthly visits43.9K
▲ 1.6% vs previous month
- Unique visitors9K
per month
- Global rank#583,901
among all websites
- Category rank#609
Health · Biotechnology and Pharmaceuticals
- Bounce rate14%
- Pages per visit8.4
- Average visit8 min 59 sec
- DevicesDesktop 69% · Mobile 31%
Websites whose visitors overlap most with Shinpung Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
hanall.co.kr | hanall.co.kr | 100% | – | – | – |
| kolonpharm.co.kr | 99% | – | #1,882,169 | View details | |
| sinilpharm.com | 72% | 7.5K | #2,311,059 | View details | |
yakup.com | yakup.com | 71% | – | #118,603 | – |
doctorkorea.com | doctorkorea.com | 60% | – | #7,453,684 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Shinpung Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Shinpung Pharmaceutical
Complete news archive for Shinpung Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Shinpung Pharmaceutical
10 companies that operate in the same segment as Shinpung Pharmaceutical (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shinpung Pharmaceutical
Shinpung Pharmaceutical was founded in 1962.
Shinpung Pharmaceutical is headquartered in Seoul, South Korea.
Shinpung Pharmaceutical has 832 employees.
Annual revenue of Shinpung Pharmaceutical is $162.5M as on Dec 31, 2025.
Shinpung Pharmaceutical was established in 1962 in Seoul, South Korea, within the pharmaceutical sector. Active pharmaceutical ingredients and finished drugs are produced as core operations. The companys activities are centered on manufacturing processes for these products, with a base in South Korea. Its online presence is maintained through the domain shinpoong.co.kr, supporting industry-related functions in the region.
Shinpung Pharmaceutical offers Pyramax and Health Functional Foods.
Yes, Shinpung Pharmaceutical is publicly traded on KRX under the ticker symbol 019170.
Shinpung Pharmaceutical operates through Shin Poong Pharm. Co., Ltd.